0001104659-19-033169.txt : 20190531 0001104659-19-033169.hdr.sgml : 20190531 20190531171249 ACCESSION NUMBER: 0001104659-19-033169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190528 FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cambridge Innovation Capital (Jersey) Ltd CENTRAL INDEX KEY: 0001776911 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 19871381 BUSINESS ADDRESS: STREET 1: /O BICYCLE THERAPEUTICS LIMITED STREET 2: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: /O BICYCLE THERAPEUTICS LIMITED STREET 2: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER NAME: FORMER CONFORMED NAME: Cambridge Innoation Capital (Jersey) Ltd DATE OF NAME CHANGE: 20190515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 a4.xml 4 X0306 4 2019-05-28 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001776911 Cambridge Innovation Capital (Jersey) Ltd C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 0 0 1 0 Ordinary Shares 2019-05-28 4 C 0 1081823 A 1081823 D Ordinary Shares 2019-05-28 4 X 0 125587 A 1207410 D Ordinary Shares 2019-05-28 4 C 0 229741 A 1437151 D Ordinary Shares 2019-05-29 4 P 0 314286 14 A 1751437 D Series B1 Preferred Shares 2019-05-28 4 C 0 1081823 D Ordinary Shares 1081823 0 D Series B1 Preferred Shares Warrants 2019-05-28 4 X 0 125587 D Ordinary Shares 125587 0 D Series B2 Preferred Shares 2019-05-28 4 C 0 229741 D Ordinary Shares 229741 0 D Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date. Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering. /s/ Rob Sprawson By: Rob Sprawson Its: Director 2019-05-31